||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 592 active entries
7150 rue Frederick-Banting, Suite 200
Saint-Laurent, H4S 2A1
Phone: (514) 282-9990
Fax: (514) 282-9990
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
BioAxone Therapeutic, a neuroscience company, is developing an experimental therapy for the treatment of neurological disorders. Our lead drug, Cethrin, is in clinical trial for spinal cord injury throughout Canada and the United States. The modified C3 exoenzyme provides neuroprotection and neuroregeneration by inhibiting Rho GTPase signaling.
- - General
Last update of this entry: October 12, 2006
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking